Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuan Wang
Institution:
Affiliated Hospital of Hebei University
Observed institution:
Affiliated Hospital of Hebei University
ORCID:
0000-0001-7750-3587
Observed ORCID:
0000-0001-7750-3587
OpenAlex ID:
A5125211794
ACSL4 as a potential ferroptosis target in hepatocellular carcinoma: from mechanisms to implications
2026
·
Yong Cui
, Meng Sun
, et al.
·
European journal of medical research
·
4
Supplementary Figure S4 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S5 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S11 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S14 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S1 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S7 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S12 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S4 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S2 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S7 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S6 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S5 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S16 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S9 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S10 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S8 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S3 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S3 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S6 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S15 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S13 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S1 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Figure S2 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Supplementary Table S4 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026
·
Nofar Gumpert
, Shira Sagie
, et al.
Show more works
View as search
Works count:
48
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type